Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed)
Clinical trial NCT06380738 · RECRUITING
Trial details
- NCT number
- NCT06380738
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-02-14
- Primary completion
- 2027-02-14
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.